Anti-leukotrienes for asthma

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.

Original languageEnglish (US)
Pages (from-to)230-234
Number of pages5
JournalCurrent Opinion in Pharmacology
Issue number3
StatePublished - Jun 1 2001
Externally publishedYes


  • Cysteinyl leukotrienes
  • Eosinophils
  • Genetics
  • Immunology
  • Leukotriene modifiers
  • Molecular Medicine
  • Pharmacology

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Anti-leukotrienes for asthma'. Together they form a unique fingerprint.

Cite this